全文获取类型
收费全文 | 11012篇 |
免费 | 536篇 |
国内免费 | 58篇 |
专业分类
耳鼻咽喉 | 98篇 |
儿科学 | 741篇 |
妇产科学 | 279篇 |
基础医学 | 1187篇 |
口腔科学 | 211篇 |
临床医学 | 647篇 |
内科学 | 2227篇 |
皮肤病学 | 316篇 |
神经病学 | 535篇 |
特种医学 | 589篇 |
外国民族医学 | 1篇 |
外科学 | 1530篇 |
综合类 | 283篇 |
一般理论 | 11篇 |
预防医学 | 437篇 |
眼科学 | 510篇 |
药学 | 1132篇 |
中国医学 | 53篇 |
肿瘤学 | 819篇 |
出版年
2023年 | 70篇 |
2022年 | 166篇 |
2021年 | 320篇 |
2020年 | 168篇 |
2019年 | 233篇 |
2018年 | 273篇 |
2017年 | 216篇 |
2016年 | 269篇 |
2015年 | 272篇 |
2014年 | 364篇 |
2013年 | 514篇 |
2012年 | 717篇 |
2011年 | 771篇 |
2010年 | 425篇 |
2009年 | 320篇 |
2008年 | 555篇 |
2007年 | 541篇 |
2006年 | 455篇 |
2005年 | 430篇 |
2004年 | 405篇 |
2003年 | 336篇 |
2002年 | 327篇 |
2001年 | 295篇 |
2000年 | 294篇 |
1999年 | 255篇 |
1998年 | 138篇 |
1997年 | 104篇 |
1996年 | 138篇 |
1995年 | 106篇 |
1994年 | 79篇 |
1993年 | 81篇 |
1992年 | 126篇 |
1991年 | 169篇 |
1990年 | 136篇 |
1989年 | 137篇 |
1988年 | 142篇 |
1987年 | 103篇 |
1986年 | 110篇 |
1985年 | 128篇 |
1984年 | 85篇 |
1983年 | 90篇 |
1982年 | 44篇 |
1981年 | 47篇 |
1979年 | 69篇 |
1978年 | 49篇 |
1977年 | 61篇 |
1975年 | 48篇 |
1972年 | 41篇 |
1971年 | 44篇 |
1968年 | 44篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
33.
34.
A randomized controlled trial of electromagnetic therapy in the primary care management of venous leg ulceration 总被引:1,自引:1,他引:0
OBJECTIVE: The aim was to establish the potential efficacy, tolerabilityand side-effect profile of electromagnetic therapy as an adjunctto conventional dressings in the treatment of venous leg ulcers. METHOD: A prospective, randomized, double blind controlled clinicaltrial was carried out in a dedicated leg ulcer clinic basedin one urban general practice. Nineteen patients with leg ulcersof confirmed venous aetiology were assessed. The main outcomemeasures were rate and scale of venous leg ulcer healing, changesin patient-reported pain levels, quality of life, degree ofmobility, side effect profile and acceptability to patientsand staff. RESULTS: Sixty-eight per cent of patients attending this dedicated clinicachieved improvements in the size of their ulcer (4, 21%, healedfully) and in reduced pain levels (P < 0.05) during the trial,despite the chronicity of ulcer histories. Patients treatedwith electromagnetic therapy at 800 Hz were found at day 50to have significantly greater healing (P < 0.05) and paincontrol (P < 0.05) than placebo therapy or treatment with600 Hz. All patients reported improved mobility at the end ofthe study. The electromagnetic therapy was well tolerated bypatients, with no differences between groups in reporting adverseevents, and proved acceptable to staff. CONCLUSION: Despite the small numbers in this pilot study, electromagnetictherapy provided significant gains in the healing of venousleg ulcers and reduction in pain. Keywords. Electromagnetic therapy, RCT, leg ulcers, primary care. 相似文献
35.
36.
37.
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. 总被引:1,自引:0,他引:1 下载免费PDF全文
S Todo J J Fung T E Starzl A Tzakis H Doyle K Abu-Elmagd A Jain R Selby O Bronsther W Marsh et al. 《Annals of surgery》1994,220(3):297-309
OBJECTIVE: The efficacy for primary orthotopic liver transplantation of a new immunosuppressive agent, FK 506 (tacrolimus, Prograf, Fujisawa USA, Deerfield, IL), was determined. SUMMARY BACKGROUND DATA: After 3 years of preclinical research, a clinical trial of FK 506 for orthotopic liver transplantation was begun in February 1989, first as a rescue therapy for patients with intractable rejection with conventional immunosuppression, then as a primary drug. METHODS: Between August 1989 and December 1993, 1391 recipients (1188 adult and 203 pediatric) of primary liver allografts were treated with FK 506 from the outset. Results from these patients were analyzed and compared with those of 1212 historical control patients (971 adult and 241 pediatric) given cyclosporine-based immunosuppression. RESULTS: Actuarial survival at 4 years was 86.2% with FK 506 versus 65.5% with cyclosporine in the pediatric patients (p < 0.0000) and 71.4% versus 65.5% in the adults (p < 0.0005). The need for retransplantation was reduced significantly for FK 506 patients. Four-year graft survival was 77.0% with FK 506 versus 48.4% with cyclosporine in the pediatric patients (p < 0.0000), and 61.9% with FK 506 versus 51.4% with cyclosporine in the adult recipients (p < 0.0000). Regression analysis revealed that reduction in mortality or graft loss from uncontrollable rejection, sepsis, technical failure, and recurrent original liver disease were responsible for the improved results with FK 506 therapy. CONCLUSIONS: FK 506 is a potent and superior immunosuppressive agent for orthotopic liver transplantation. 相似文献
38.
To identify the role of protein kinase C (PKC) isoforms in multidrug resistance in tumor cells, we examined the PKC isoform pattern in the multidrug resistant P388/ADR cell line and studied the effect of down regulation of PKC isoforms on intracellular daunorubicin accumulation and P-glycoprotein expression. Using monoclonal antibodies to PKC alpha, beta and gamma and flow cytometry technique we showed that P388/ADR cells overexpressed PKC alpha and beta as compared to drug sensitive P388 cells. Prolonged treatment of P388/ADR cells with phorbol myristate acetate (PMA), a procedure that is known to down regulate PKC, resulted in the down regulation of total PKC activity and the PKC beta isoform (at the protein level) that was accompanied by the correction of daunorubicin accumulation in P388/ADR cells. The level of expression of P-glycoprotein in PMA treated cells was similar to that of untreated cells. These results suggest that PKC beta regulates the drug efflux function of P-glycoprotein. 相似文献
39.
Fertility reduction and the quality of family planning services 总被引:5,自引:0,他引:5
A K Jain 《Studies in family planning》1989,20(1):1-16
The purpose of this paper is to determine whether a focus on quality of family planning services is consistent with meeting demographic objectives. An analytical framework that links the six elements of quality with fertility is described. A review of existing literature and analysis suggest that improvements in quality of family planning services by enhancing the choice of contraceptive methods available in a country would increase the overall practice of contraception and thus would result in fertility reduction. 相似文献
40.
Compound 5a ([Z]-1, 1-Dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane) is a novel cyclopropyl compound which was shown to be a pure antiestrogen. In the present study, the antiproliferative activity of 5a was examined on estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 human breast cancer cells and A-549 human lung cancer cells using the hemocytometric trypan blue exclusion method. Compound 5a inhibited the growth of MCF-7 cells in a dose-related manner over a concentration range of 10(-9) to 10(-5) M, but did not alter the growth of MDA-MB-231 or A-549 cells. Co-administration of estradiol (10(-8) M) reversed the antiproliferative activity of 5a (10(-7) M) on MCF-7 cells. Further, an ER-dependent mechanism of action is supported by the specific ER binding of 5a in MCF-7 cells observed in this study. The influence of 5a on the cell surface morphology of MCF-7 and MDA-MB-231 cells was studied using scanning electron microscopy (SEM). Compound 5a at 10(-6) M reduced the length and density of microvilli (MV) on MCF-7 cells, which was reversed by co-administration of estradiol (10(-8) M). This compound did not alter the cell surface morphology of ER-negative MDA-MB-231 cells. In conclusion, 5a and tamoxifen inhibited the growth of ER-prositive MCF-7 cells in an estradiol-reversible manner, and had no effect on ER-negative MDA-MB-231 cells. The results of this study with human breast cancer cells suggest that 5a may be highly effective in the treatment of estrogen-dependent breast cancer and/or in the prophylactic treatment of women with a high risk of breast cancer development. 相似文献